SCA practice case · Video consultation
“I paid for a full health MOT and it’s flagged nine things — I need you to go through every one and refer me”
Video consultation
Adult patient
Typical
Investigations & resultsLong-term conditions & cancerProfessional & ethical dilemmas
The candidate brief
This is what you would read in the 3-minute window before the patient connects. Read it once, note two or three hypotheses and one thing you must not miss, then stop.
Patient
Paul Cresswell · 48 years · male
Setting
Video consultation — to discuss the results of a privately arranged blood test.
Past history
- Obesity (BMI 33)
- Ex-smoker
Medication
- None prescribed
Allergies
None recorded
Recent notes
Uploaded a private blood test report (36 markers, nine flagged). Pharmacy BP last week 146/92. No previous cardiovascular risk assessment recorded.
Reason for contact
“Go through my private blood results.”
Practise this case
The full case is in the Hot Seat with the Gold plan. You get a 12-minute timer, a role-player script with facts released only when asked, examiner checkpoints by the three RCGP domains, a model consultation and the guidance behind it.
What this case tests
Show the learning points (spoiler: read after you have practised)
People increasingly bring results from private, direct-to-consumer blood panels. GMC guidance is that doctors must act on clinically significant information, whatever its source, but the NHS is not obliged to repeat private screening tests on request or provide follow-up for every flagged marker. The skill is prioritisation. Panels flag results that are statistically outside a range rather than clinically important, may use unsuitable samples (finger-prick, non-fasting, afternoon testosterone) and include tests that need counselling (PSA). Here the important signal is cardiovascular: raised non-HDL cholesterol, low HDL, high triglycerides, non-diabetic hyperglycaemia, obesity, raised blood pressure, ex-smoking and a brother with a heart attack at 50, which is a family history of premature CVD that QRISK3 includes. NICE NG238 (2023) recommends formal risk assessment with QRISK3, lifestyle advice, and offering atorvastatin for primary prevention when risk is 10% or more, after confirming lipids. Blood pressure should be confirmed with home or ambulatory monitoring (NICE NG136). A raised ALT with metabolic risk factors is most often metabolic dysfunction-associated steatotic liver disease (MASLD, previously NAFLD): repeat venous LFTs, a liver aetiology screen, assess alcohol, and use FIB-4 (with ELF if indeterminate) to decide on referral (NICE NG49). Raised ferritin is commonly inflammatory or metabolic, but transferrin saturation excludes haemochromatosis. HbA1c 42–47 mmol/mol is non-diabetic hyperglycaemia (NICE PH38): repeat annually and offer the NHS Diabetes Prevention Programme. Vitamin D supplementation is a self-care purchase for most adults. An isolated hs-CRP and an afternoon testosterone without symptoms are not actionable. The hidden agenda, fear after a sibling’s heart attack, explains the demand for repeated testing; addressing it directly and channelling it into risk reduction is the heart of the consultation.
The guidance behind it
Similar SCA cases
gpreasoning.uk is not affiliated with or endorsed by the RCGP. Our cases are original teaching material written for practice; none is an exam recall. For anything official about the SCA, check the RCGP SCA pages.